U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C27H39NO3
Molecular Weight 425.6035
Optical Activity UNSPECIFIED
Defined Stereocenters 10 / 10
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of JERVINE

SMILES

C[C@@H]1[C@@H]2NC[C@@H](C)C[C@H]2O[C@]13CC[C@H]4[C@@H]5CC=C6C[C@@H](O)CC[C@]6(C)[C@H]5C(=O)C4=C3C

InChI

InChIKey=CLEXYFLHGFJONT-DNMILWOZSA-N
InChI=1S/C27H39NO3/c1-14-11-21-24(28-13-14)16(3)27(31-21)10-8-19-20-6-5-17-12-18(29)7-9-26(17,4)23(20)25(30)22(19)15(27)2/h5,14,16,18-21,23-24,28-29H,6-13H2,1-4H3/t14-,16+,18-,19-,20-,21+,23+,24-,26-,27-/m0/s1

HIDE SMILES / InChI

Molecular Formula C27H39NO3
Molecular Weight 425.6035
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 10 / 10
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including: https://en.wikipedia.org/wiki/Jervine | https://www.google.com/patents/US20150259313

Jervine (11-Ketocyclopamine) is a naturally occuring steroidal alkaloid is derived from the Veratrum plant species. Jervine is a teratogen implicated in birth defects when consumed by animals during a certain period of their gestation. Over the Hedgehog signaling pathway Jervine effectively inhibit the tumor growth using three human tumor xenograft models including lung cancer, pancreatic cancer and basal cell carcinoma. Jervine has the potential to advance to a treatment for different tumors.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
50.0 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Hedgehog signaling is required at multiple stages of zebrafish tooth development.
2010-11-30
Characterization and identification of steroidal alkaloids in Fritillaria species using liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry.
2010-11-05
Ingestion of false hellebore plants can cross-react with a digoxin clinical chemistry assay.
2010-06
Antitumor and antiplatelet activity of alkaloids from veratrum dahuricum.
2010-06
Synthesis of all diastereomers of the piperidine--alkaloid substructure of cyclopamine.
2009-12-03
Smoothened adopts multiple active and inactive conformations capable of trafficking to the primary cilium.
2009
Accidental intoxication with Veratrum album.
2008-11-22
Antitumor activity of extracts and compounds from the rhizomes of Veratrum dahuricum.
2008-08
A study on the chemical constituents of Veratrum nigrum L. processed by rice vinegar.
2008-07-19
Isolation, purification, and full NMR assignments of cyclopamine from Veratrum californicum.
2008-06-24
[Determination of jervine and veratramine in Veratrum plants using high performance liquid chromatography coupled with evaporative light scattering detection].
2008-01
Factors that regulate embryonic gustatory development.
2007-09-18
Critical time window of hedgehog-dependent angiogenesis in murine yolk sac.
2006-03
Sonic hedgehog exerts distinct, stage-specific effects on tongue and taste papilla development.
2004-12-15
Glycoalkaloids and metabolites inhibit the growth of human colon (HT29) and liver (HepG2) cancer cells.
2004-05-19
Cyclopamine and jervine in embryonic rat tongue cultures demonstrate a role for Shh signaling in taste papilla development and patterning: fungiform papillae double in number and form in novel locations in dorsal lingual epithelium.
2003-02-01
Development of an enzyme-linked immunosorbent assay for the veratrum plant teratogens: cyclopamine and jervine.
2003-01-29
Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists.
2002-11-06
Roughing up Smoothened: chemical modulators of hedgehog signaling.
2002-11-06
Prx1 and Prx2 are upstream regulators of sonic hedgehog and control cell proliferation during mandibular arch morphogenesis.
2001-08
Patents

Sample Use Guides

Oral: 40 or 60 or 80 mg/kg once every day (during 21 days). Intravenous: 20 or 40 or 80 mg/kg once every day (during 21 days).
Route of Administration: Other
Tongues treated with jervine at 10 μM exhibited a dorsal anterior tongue that was almost completely occupied by fungiform papillae.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:58:03 GMT 2025
Edited
by admin
on Mon Mar 31 18:58:03 GMT 2025
Record UNII
19V3ECX465
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-23898
Preferred Name English
JERVINE
HSDB   MI  
Common Name English
JERVINE [HSDB]
Common Name English
NSC-7520
Code English
VERATRAMAN-11-ONE, 17,23-EPOXY-3-HYDROXY-, (3.BETA.,23.BETA.)-
Common Name English
SPIRO(9H-BENZO(A)FLUORENE-9,2'(3'H)-FURO(3,2-B)PYRIDIN)-11(1H)-ONE, 2,3,3'A,4,4',5',6,6',6A,6B,7,7',7'A,8,11A,11B-HEXADECAHYDRO-3-HYDROXY-3',6',10,11B-TETRAMETHYL-, (2'R,3S,3'R,3'AS,6'S,6AS,6BS,7'AR,11AS,11BR)-
Systematic Name English
JERVIN
Common Name English
JERVINE [MI]
Common Name English
Code System Code Type Description
PUBCHEM
10098
Created by admin on Mon Mar 31 18:58:03 GMT 2025 , Edited by admin on Mon Mar 31 18:58:03 GMT 2025
PRIMARY
MESH
C010206
Created by admin on Mon Mar 31 18:58:03 GMT 2025 , Edited by admin on Mon Mar 31 18:58:03 GMT 2025
PRIMARY
MERCK INDEX
m6582
Created by admin on Mon Mar 31 18:58:03 GMT 2025 , Edited by admin on Mon Mar 31 18:58:03 GMT 2025
PRIMARY Merck Index
CAS
469-59-0
Created by admin on Mon Mar 31 18:58:03 GMT 2025 , Edited by admin on Mon Mar 31 18:58:03 GMT 2025
PRIMARY
HSDB
3502
Created by admin on Mon Mar 31 18:58:03 GMT 2025 , Edited by admin on Mon Mar 31 18:58:03 GMT 2025
PRIMARY
ECHA (EC/EINECS)
207-417-9
Created by admin on Mon Mar 31 18:58:03 GMT 2025 , Edited by admin on Mon Mar 31 18:58:03 GMT 2025
PRIMARY
EPA CompTox
DTXSID70895026
Created by admin on Mon Mar 31 18:58:03 GMT 2025 , Edited by admin on Mon Mar 31 18:58:03 GMT 2025
PRIMARY
WIKIPEDIA
JERVINE
Created by admin on Mon Mar 31 18:58:03 GMT 2025 , Edited by admin on Mon Mar 31 18:58:03 GMT 2025
PRIMARY
NSC
23898
Created by admin on Mon Mar 31 18:58:03 GMT 2025 , Edited by admin on Mon Mar 31 18:58:03 GMT 2025
PRIMARY
NSC
7520
Created by admin on Mon Mar 31 18:58:03 GMT 2025 , Edited by admin on Mon Mar 31 18:58:03 GMT 2025
PRIMARY
FDA UNII
19V3ECX465
Created by admin on Mon Mar 31 18:58:03 GMT 2025 , Edited by admin on Mon Mar 31 18:58:03 GMT 2025
PRIMARY
Related Record Type Details
TRANSPORTER -> INHIBITOR
Showed a concentration-dependent manner, stimulation of ABCB1-ATPase activity, and had a weaker effect than the verapamil.
Related Record Type Details
ACTIVE MOIETY